These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 10448271)
1. p53 gene mutations and p21 protein expression induced independently of p53, by TGF-beta and gamma-rays in squamous cell carcinoma cells. Yoneda K; Yokoyama T; Yamamoto T; Hatabe T; Osaki T Eur J Cancer; 1999 Feb; 35(2):278-83. PubMed ID: 10448271 [TBL] [Abstract][Full Text] [Related]
2. p53- and p21-independent apoptosis of squamous cell carcinoma cells induced by 5-fluorouracil and radiation. Yoneda K; Yamamoto T; Osaki T Oral Oncol; 1998 Nov; 34(6):529-37. PubMed ID: 9930367 [TBL] [Abstract][Full Text] [Related]
3. Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells. Ala-aho R; Grénman R; Seth P; Kähäri VM Oncogene; 2002 Feb; 21(8):1187-95. PubMed ID: 11850838 [TBL] [Abstract][Full Text] [Related]
4. p21 expression is increased by irradiation in esophageal squamous cell carcinoma. Rigberg DA; Kim FS; Blinman TA; Cole MA; Lane JS; So J; McFadden DW J Surg Res; 1998 May; 76(2):137-42. PubMed ID: 9698513 [TBL] [Abstract][Full Text] [Related]
5. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression. Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587 [TBL] [Abstract][Full Text] [Related]
6. Induction of cyclin-dependent kinase inhibitor p21 in vesnarinone-induced differentiation of squamous cell carcinoma cells. Yoneda K; Yamamoto T; Ueta E; Osaki T Cancer Lett; 1998 Nov; 133(1):35-45. PubMed ID: 9929158 [TBL] [Abstract][Full Text] [Related]
7. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions. Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708 [TBL] [Abstract][Full Text] [Related]
8. Mutations of the cell cycle regulatory genes p16INK4A and p21WAF1 and the metastasis-inducing gene S100A4 are infrequent and unrelated to p53 tumour suppressor gene status and data on survival in oropharyngeal squamous cell carcinomas. Ibrahim SO; Lillehaug JR; Vasstrand EN Anticancer Res; 2003; 23(6C):4593-600. PubMed ID: 14981901 [TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells. Gong J; Ammanamanchi S; Ko TC; Brattain MG Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668 [TBL] [Abstract][Full Text] [Related]
10. Sensitivity to transforming growth factor beta 1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC down-regulation and p21waf1 induction are important early events. Malliri A; Yeudall WA; Nikolic M; Crouch DH; Parkinson EK; Ozanne B Cell Growth Differ; 1996 Oct; 7(10):1291-304. PubMed ID: 8891333 [TBL] [Abstract][Full Text] [Related]
11. Mn-SOD antisense upregulates in vivo apoptosis of squamous cell carcinoma cells by anticancer drugs and gamma-rays regulating expression of the BCL-2 family proteins, COX-2 and p21. Ueta E; Yoneda K; Kimura T; Tatemoto Y; Doi S; Yamamoto T; Osaki T Int J Cancer; 2001 Nov; 94(4):545-50. PubMed ID: 11745442 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of cell growth by transforming growth factor beta 1 is associated with p53-independent induction of p21 in gastric carcinoma cells. Akagi M; Yasui W; Akama Y; Yokozaki H; Tahara H; Haruma K; Kajiyama G; Tahara E Jpn J Cancer Res; 1996 Apr; 87(4):377-84. PubMed ID: 8641969 [TBL] [Abstract][Full Text] [Related]
13. Cyclosporine induces the expression of the cyclin inhibitor p21. Khanna AK; Hosenpud JD Transplantation; 1999 May; 67(9):1262-8. PubMed ID: 10342319 [TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Elbendary A; Berchuck A; Davis P; Havrilesky L; Bast RC; Iglehart JD; Marks JR Cell Growth Differ; 1994 Dec; 5(12):1301-7. PubMed ID: 7696178 [TBL] [Abstract][Full Text] [Related]
15. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells. Miyazaki M; Sakaguchi M; Akiyama I; Sakaguchi Y; Nagamori S; Huh NH Cancer Res; 2004 Jun; 64(12):4155-61. PubMed ID: 15205326 [TBL] [Abstract][Full Text] [Related]
16. Mutation in p53 and de-regulation of p53-related gene expression in three human cell lines immortalized with 4-nitroquinoline 1-oxide or 60Co gamma rays. Iijima M; Mihara K; Kondo T; Tsuji T; Ishioka C; Namba M Int J Cancer; 1996 May; 66(5):698-702. PubMed ID: 8647635 [TBL] [Abstract][Full Text] [Related]
17. Radio-induced modulation of transforming growth factor beta1 sensitivity in a p53 wild-type human colorectal-cancer cell line. Suardet L; Li C; Little JB Int J Cancer; 1996 Sep; 68(1):126-31. PubMed ID: 8895552 [TBL] [Abstract][Full Text] [Related]
18. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Fan S; el-Deiry WS; Bae I; Freeman J; Jondle D; Bhatia K; Fornace AJ; Magrath I; Kohn KW; O'Connor PM Cancer Res; 1994 Nov; 54(22):5824-30. PubMed ID: 7954409 [TBL] [Abstract][Full Text] [Related]
19. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines. Akama Y; Yasui W; Kuniyasu H; Yokozaki H; Akagi M; Tahara H; Ishikawa T; Tahara E Jpn J Cancer Res; 1996 Aug; 87(8):824-30. PubMed ID: 8797888 [TBL] [Abstract][Full Text] [Related]
20. Reduced messenger RNA expression level of p21 CIP1 in human colorectal carcinoma tissues and its association with p53 gene mutation. Matsushita K; Kobayashi S; Kato M; Itoh Y; Okuyama K; Sakiyama S; Isono K Int J Cancer; 1996 Aug; 69(4):259-64. PubMed ID: 8797864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]